Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;5(Suppl 1):S21-4.

Resistant hypertension: current status, future challenges

Affiliations
Review

Resistant hypertension: current status, future challenges

Niloofar Hajizadeh et al. Int J Prev Med. 2014 Mar.

Abstract

Resistant hypertension in adolescents is increasing in frequency and is increasingly recognized as having significant short- and long-term health consequences. It may be seen in up to 30% of all hypertensive patients cared for. Adolescents with resistant hypertension are at higher cardiovascular (CV) risk due to a long history of severe hypertension complicated by other CV risk factors such as obesity. Common causes of resistant hypertension include primary aldosteronism, sleep apnea, diabetes and chronic kidney disease. Careful blood pressure (BP) measurement and thorough evaluation of patients with sustained BP elevation should make a possible early diagnosis of resistant hypertension. Successful treatment requires identification and reversal of life-style factors contributing to treatment resistant and diagnosis and appropriate treatment of causes of hypertension. Improved pharmacologic therapies may offer the potential for preventing or at least ameliorating early CV disease. This review highlights these and other important issues in the evaluation and management of adolescents with resistant hypertension and provides practical guidance to the practitioners involved in caring for such patients.

Keywords: Cardiovascular disease; children and adolescents; prevention; resistant hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Assadi F. The growing epidemic of hypertension among children and adolescents: A challenging road ahead. Pediatr Cardiol. 2012;33:1013–20. - PubMed
    1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–26. - PubMed
    1. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR RUSH University Hypertension Service. Resistant hypertension revisited: A comparison of two university-based cohorts. Am J Hypertens. 2005;18:619–26. - PubMed
    1. Assadi F. Strategies to reduce the incidence of chronic kidney disease in children: Time for action. J Nephrol. 2013;26:41–7. - PubMed
    1. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;19:2063–70. - PubMed